Skip to content
drillr.ai
Sign up

TSHA

Taysha Gene Therapies, Inc.

NASDAQ · Healthcare · Biotechnology · US

$5.60
+0.54%
Ask drillr
0
Insider buys (3m)
1
Insider sells (3m)
-$1.2M
Net value (3m)
+0.1%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jul 10, 2026Nagendran Sukumar · director, officer: President and Head of R&DSale200,000$6.24
Jun 2, 2026Long Alison S · directorA-Award21,335$0.00
Jun 2, 2026Long Alison S · directorA-Award42,671$5.97
Jun 2, 2026Sepp-Lorenzino Laura · directorA-Award21,335$0.00
Jun 2, 2026Sepp-Lorenzino Laura · directorA-Award42,671$5.97
Jun 2, 2026Donenberg Phillip B. · directorA-Award42,671$5.97
Jun 2, 2026Stalfort John A III · directorA-Award21,335$0.00
Jun 2, 2026Stalfort John A III · directorA-Award42,671$5.97
Jun 2, 2026Donenberg Phillip B. · directorA-Award21,335$0.00
Apr 13, 2026Nagendran Sukumar · director, officer: President and Head of R&DM-Exempt19,021$1.71
Apr 13, 2026Nagendran Sukumar · director, officer: President and Head of R&DSale200,000$4.46
Feb 6, 2026Alam Kamran · officer: CHIEF FINANCIAL OFFICERSale1,655$4.52
Jan 27, 2026Alam Kamran · officer: CHIEF FINANCIAL OFFICERSale23,849$4.61
Jan 27, 2026Nagendran Sukumar · director, officer: President and Head of R&DSale26,918$4.61
Jan 27, 2026Nolan Sean P. · director, officer: Chief Executive OfficerSale136,789$4.75
Jan 27, 2026Nagendran Sukumar · director, officer: President and Head of R&DSale89,132$4.75
Jan 27, 2026Nolan Sean P. · director, officer: Chief Executive OfficerSale41,312$4.61
Jan 27, 2026Alam Kamran · officer: CHIEF FINANCIAL OFFICERSale78,968$4.75
Jan 14, 2026Nolan Sean P. · director, officer: Chief Executive OfficerA-Award648,000$4.86
Jan 14, 2026Alam Kamran · officer: CHIEF FINANCIAL OFFICERA-Award359,000$0.00
Jan 14, 2026Alam Kamran · officer: CHIEF FINANCIAL OFFICERA-Award231,000$4.86
Jan 14, 2026Nolan Sean P. · director, officer: Chief Executive OfficerA-Award1,008,000$0.00
Jan 14, 2026Nagendran Sukumar · director, officer: President and Head of R&DA-Award427,000$0.00
Jan 14, 2026Nagendran Sukumar · director, officer: President and Head of R&DM-Exempt88,676$1.71
Jan 14, 2026Nagendran Sukumar · director, officer: President and Head of R&DM-Exempt111,324$0.70
Jan 14, 2026Nagendran Sukumar · director, officer: President and Head of R&DSale200,000$4.71
Jan 14, 2026Nagendran Sukumar · director, officer: President and Head of R&DA-Award274,000$4.86
Dec 1, 2025Nagendran Sukumar · director, officer: President and Head of R&DM-Exempt39,953$1.71
Dec 1, 2025Nagendran Sukumar · director, officer: President and Head of R&DM-Exempt70,172$0.70
Dec 1, 2025Nagendran Sukumar · director, officer: President and Head of R&DSale110,125$4.75
Institutional positioning

13F filings over the trailing two quarters

New 36Increased 69Reduced 55Sold out 189
FilerActionSharesFiled
RA CAPITAL MANAGEMENT, L.P.Unchanged23,555,648May 15, 2026
GOLDMAN SACHS GROUP INCReduced22,369,645May 15, 2026
AVORO CAPITAL ADVISORS LLCReduced21,700,000May 15, 2026
AVORO CAPITAL ADVISORS LLCUnchanged21,700,000Mar 16, 2026
BLACKROCK, INC.Reduced18,365,608May 13, 2026
VESTAL POINT CAPITAL, LPIncreased18,000,000May 15, 2026
MORGAN STANLEYReduced17,965,371May 15, 2026
FMR LLCIncreased14,321,255May 15, 2026
GOLDMAN SACHS GROUP INCIncreased13,692,739Mar 25, 2026
RTW INVESTMENTS, LPReduced13,680,248May 15, 2026
STATE STREET CORPIncreased11,209,078May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position10,231,502May 15, 2026
OCTAGON CAPITAL ADVISORS LPUnchanged8,859,911May 15, 2026
SIREN, L.L.C.Reduced8,829,913May 14, 2026
POLAR CAPITAL HOLDINGS PLCReduced5,654,340May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 10, 2026